Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient: A case report.

DAL may present with voluminous lymphadenopathy consistent with malignancy in clinical and imaging workup. We describe the spectrum of lesions associated with DAL and identify common features with drug-induced lymphadenopathy.